Ticker name:KYMRKymera Therapeutics, Inc.
Country: US-Sector: Healthcare, Industry: Biotechnology
Kymera Therapeutics, Inc. is a biopharmaceutical company dedicated to discovering and developing pioneering small molecule therapeutics. These treatments operate by harnessing the body's inherent protein degradation system to selectively eliminate disease-causing proteins. The company's pipeline features several programs, including the IRAK4 program, currently in Phase I clinical trials, which targets various immunology-inflammation disorders such as hidradenitis suppurativa, atopic dermatitis, macrophage activation syndrome, generalized pustular psoriasis, and rheumatoid arthritis. Additionally, Kymera is advancing its IRAKIMiD program, designed to address MYD88-mutated diffuse large B cell lymphoma. Other key programs include the STAT3 program, focused on hematological malignancies, solid tumors, autoimmune diseases, and fibrosis, as well as the MDM2 program, which is also aimed at hematological malignancies and solid tumors. The company was founded in 2015 and maintains its headquarters in Watertown, Massachusetts.
- CEO: Nello Mainolfi
- IPO: Aug 21, 2020
- Website:kymeratx.com (open a new tab)
Market Cap 12B
Last close 136.25$
Key metrics
Largest 20 companies In Biotechnology
| # Position | Ticker | Company Name | Market Cap | Last Price | Action |
|---|---|---|---|---|---|
| 1 | VRTX | VERTEX PHARMACEUTICALS INC / MA | 139B | 549.04$ | |
| 2 | MRNA | Moderna, Inc. | 103B | 258.38$ | |
| 3 | REGN | REGENERON PHARMACEUTICALS, INC. | 96B | 930.67$ | |
| 4 | RVMD | Revolution Medicines, Inc. | 43B | 199.7$ | |
| 5 | GMAB | GENMAB A/S | 34B | 55.12$ | |
| 6 | ROIV | Roivant Sciences Ltd. | 28B | 38.23$ | |
| 7 | UTHR | UNITED THERAPEUTICS Corp | 26B | 608.49$ | |
| 8 | INCY | INCYTE CORP | 25B | 122.85$ | |
| 9 | INSM | INSMED Inc | 24B | 110$ | |
| 10 | ALNY | ALNYLAM PHARMACEUTICALS, INC. | 22B | 161.08$ | |
| 11 | EXEL | EXELIXIS, INC. | 18B | 72.75$ | |
| 12 | ASND | Ascendis Pharma A/S | 17B | 257.93$ | |
| 13 | NBIX | NEUROCRINE BIOSCIENCES INC | 17B | 166.05$ | |
| 14 | BBIO | BridgeBio Pharma, Inc. | 15B | 77.89$ | |
| 15 | JAZZ | Jazz Pharmaceuticals plc | 15B | 234.66$ | |
| 16 | HALO | HALOZYME THERAPEUTICS, INC. | 15B | 130.34$ | |
| 17 | SMMT | Summit Therapeutics Inc. | 13B | 16.17$ | |
| 18 | KYMR | Kymera Therapeutics, Inc. | 12B | 136.25$ | |
| 19 | TECH | BIO-TECHNE Corp | 11B | 72.73$ | |
| 20 | BMRN | BIOMARIN PHARMACEUTICAL INC | 11B | 57.13$ |